Annual CFO
-$55.84 M
-$12.21 M-27.99%
December 31, 2023
Summary
- As of February 7, 2025, AVBP annual cash flow from operations is -$55.84 million, with the most recent change of -$12.21 million (-27.99%) on December 31, 2023.
- AVBP annual CFO is now -27.99% below its all-time high of -$43.63 million, reached on December 31, 2022.
Performance
AVBP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$16.34 M
+$2.74 M+14.37%
September 1, 2024
Summary
- As of February 7, 2025, AVBP quarterly cash flow from operations is -$16.34 million, with the most recent change of +$2.74 million (+14.37%) on September 1, 2024.
- Over the past year, AVBP quarterly CFO has increased by +$2.74 million (+14.37%).
- AVBP quarterly CFO is now -89.93% below its all-time high of -$8.61 million, reached on June 1, 2023.
Performance
AVBP Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$68.97 M
-$903.00 K-1.33%
September 1, 2024
Summary
- As of February 7, 2025, AVBP TTM cash flow from operations is -$68.97 million, with the most recent change of -$903.00 thousand (-1.33%) on September 1, 2024.
- Over the past year, AVBP TTM CFO has dropped by -$903.00 thousand (-1.33%).
- AVBP TTM CFO is now -148.61% below its all-time high of -$27.74 million, reached on September 1, 2022.
Performance
AVBP TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
AVBP Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.0% | +14.4% | -1.3% |
| 3 y3 years | - | +14.4% | -1.3% |
| 5 y5 years | - | +14.4% | -1.3% |
AVBP Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -28.0% | at low | -89.9% | +41.1% | -148.6% | at low |
| 5 y | 5-year | -28.0% | at low | -89.9% | +41.1% | -148.6% | at low |
| alltime | all time | -28.0% | at low | -89.9% | +41.1% | -148.6% | at low |
ArriVent BioPharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$16.34 M(-14.4%) | -$68.97 M(+1.3%) |
| Jun 2024 | - | -$19.09 M(+2.5%) | -$68.07 M(+18.2%) |
| Mar 2024 | - | -$18.63 M(+24.9%) | -$57.59 M(+3.1%) |
| Dec 2023 | -$55.84 M | -$14.91 M(-3.4%) | -$55.84 M(+36.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$15.44 M(+79.4%) | -$40.93 M(-23.1%) |
| Jun 2023 | - | -$8.61 M(-49.0%) | -$53.23 M(+19.3%) |
| Mar 2023 | - | -$16.88 M(-39.2%) | -$44.63 M(+60.8%) |
| Dec 2022 | -$43.63 M | - | - |
| Sep 2022 | - | -$27.74 M | -$27.74 M |
FAQ
- What is ArriVent BioPharma annual cash flow from operations?
- What is the all time high annual CFO for ArriVent BioPharma?
- What is ArriVent BioPharma annual CFO year-on-year change?
- What is ArriVent BioPharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for ArriVent BioPharma?
- What is ArriVent BioPharma quarterly CFO year-on-year change?
- What is ArriVent BioPharma TTM cash flow from operations?
- What is the all time high TTM CFO for ArriVent BioPharma?
- What is ArriVent BioPharma TTM CFO year-on-year change?
What is ArriVent BioPharma annual cash flow from operations?
The current annual CFO of AVBP is -$55.84 M
What is the all time high annual CFO for ArriVent BioPharma?
ArriVent BioPharma all-time high annual cash flow from operations is -$43.63 M
What is ArriVent BioPharma annual CFO year-on-year change?
Over the past year, AVBP annual cash flow from operations has changed by -$12.21 M (-27.99%)
What is ArriVent BioPharma quarterly cash flow from operations?
The current quarterly CFO of AVBP is -$16.34 M
What is the all time high quarterly CFO for ArriVent BioPharma?
ArriVent BioPharma all-time high quarterly cash flow from operations is -$8.61 M
What is ArriVent BioPharma quarterly CFO year-on-year change?
Over the past year, AVBP quarterly cash flow from operations has changed by +$2.74 M (+14.37%)
What is ArriVent BioPharma TTM cash flow from operations?
The current TTM CFO of AVBP is -$68.97 M
What is the all time high TTM CFO for ArriVent BioPharma?
ArriVent BioPharma all-time high TTM cash flow from operations is -$27.74 M
What is ArriVent BioPharma TTM CFO year-on-year change?
Over the past year, AVBP TTM cash flow from operations has changed by -$903.00 K (-1.33%)